Professor Phillippe Grandjean calls for new methods of risk assessment to ensure PFAS replacements are evaluated properly before use.
Evidence that PFAS chemicals PFOA and PFOS are toxic to the immune (reticuloendothelial) system has existed since the 1970s, but this evidence was not made publicly available until 2000, and is still not necessarily taken into account in risk assessment. Findings of some early company-led studies indicating the immunity of workers might be affected by PFOA were never published after apparent disagreements over the wording of the conclusions.
It has taken decades for action to be taken. Both PFOA and PFOS are now restricted by international regulation due to concerns for the environment and human health. PFOS was added to the Stockholm convention of Persistent Organic Pollutants in 2009, while PFOA will be restricted under the European chemicals legislation REACH by 2020. Both chemicals continue to be used in certain specialised applications, and PFOA can still be used to make products outwith the European Union (see Regulations).
Safe unless proven unsafe?
Professor Grandjean has highlighted how chemical risk is often assessed on the assumption that industrial chemicals are “inert, or safe, unless proven otherwise”. It can take decades for scientific evidence to lead to intervention on a policy level.
PFOA and PFOS have been phased out of many textile uses, and the most common PFAS-based stain resistant coatings now use short-chain PFAS as alternatives to PFOA and PFOS (read more about the difference on our Background pages). These compounds have a similar chemistry, but have not been as well studied yet. Just like the chemicals they are replacing, they don’t break down in the environment, and have already been found in the environment. New evidence for their toxicity is emerging.
Professor Grandjean calls for any alternatives, whether PFAS-based or not, to be scrutinised before their widespread use. We see this as a sensible approach!
Read more about this:
Chemical Watch: Prior scrutiny needed for PFAS substitutes, expert says
The original article (open access): Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances